Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ADMA
#1816
ADMA Biologics, Inc.
10.4
9
USD
+1.06%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+1.06%
Changement Mensuel
-30.80%
Evolution sur 6 mois
-30.07%
Changement Annuel
-51.12%
Clôture Précédente
10.3
8
Open
10.4
9
Bid
Ask
Low
10.4
9
High
10.4
9
Volume
114
Marchés
Actions des Marchés US
Soins de Santé
ADMA
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
121.28 M
195.92 M
222.16 M
228.22 M
237.62 M
238.16 M
—
Valuation ratios
Enterprise value
192.3 M
227.49 M
772.01 M
992.42 M
3.98 B
4.33 B
16.77 B
Price to earnings ratio
—
-2.76
-11.73
-35
21.17
30.4
92.69
Price to sales ratio
—
2.43
4.97
3.95
9.79
8.76
36.07
Price to cash flow ratio
—
-1.75
-12.87
115.81
35.17
88.64
249.65
Price to book ratio
—
1.39
5.04
7.54
11.96
9.36
19.22
Enterprise value to EBITDA ratio
-1.47
-4.2
-23.46
33.77
27.08
21.34
96.18
Profitability ratios
Return on assets %
-0.36
-0.26
-0.19
-0.09
0.4
0.24
0.26
Return on equity %
-0.86
-0.51
-0.43
-0.21
0.57
0.31
0.35
Return on invested capital %
-237.14
-139.79
-72.03
35.93
300.15
151.01
147.02
Gross margin %
-45.17
1.45
22.89
34.44
51.48
57.39
228.49
Operating margin %
-153.75
-72.12
-25.55
8.38
32.59
37.53
148.57
EBITDA margin %
-291.35
-66.19
-21.39
11.32
34.4
39.09
154.86
Net margin %
-179.41
-88.52
-42.77
-10.94
46.35
28.8
114.11
Liquidity ratios
Quick ratio
3.62
2.77
2.73
1.69
2.9
3.74
13.52
Current ratio
7.71
6.87
6.89
5.16
5.97
6.71
25.74
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.25
0.33
0.49
0.76
1.04
0.92
0.93
Solvency ratios
Debt to assets ratio
0.06
0.01
-0
0.02
0.01
0.12
0.29
Debt to equity ratio
0.13
0.02
-0.01
0.04
0.02
0.16
0.38
Long term debt to total assets ratio
0.03
-0.02
-0.03
-0.01
-0.01
0.11
0.23
Long term debt to total equity ratio
0.08
-0.04
-0.08
-0.03
-0.01
0.15
0.3
Per share metrics
Operating cash flow per share
—
-0.81
-0.3
0.04
0.49
0.21
0.2
EBIT per share
—
-0.42
-0.2
0.1
0.57
0.78
0.78
EBITDA per share
—
-0.38
-0.17
0.13
0.6
0.81
0.81
Total debt per share
—
0.02
-0.01
0.02
0.02
0.31
0.69
Cash per share
—
0.37
0.44
0.23
0.42
0.36
1.26
Net current asset value per share
—
1.5
1.37
1.15
1.36
1.9
6.6
Tangible book value per share
—
0.97
0.75
0.59
1.42
1.93
6.77
Working capital per share
—
1.28
1.17
0.93
1.13
1.62
5.56
Book value per share
—
1.01
0.77
0.6
1.43
1.95
6.84
Nouvelles
Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes
Is ADMA Poised for Margin Growth and Supply Expansion in 2026?
Adma Biologics (ADMA) Laps the Stock Market: Here's Why
ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA)
Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?
NVO Launches Wegovy Subscription Plan, Boosts Access, Stock Up
Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio
Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study
ADMA Biologics: Differentiated Plasma Approach With Asymmetric Upside Potential (Upgrade)
Novartis Bolsters Immunology Pipeline With Excellergy Deal
Novo Nordisk's Awiqli Gets FDA Approval for Type II Diabetes
KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate